Align Technology to Release Third-Quarter 2026 Results on October 28

· · 4 mins read
Align Technology to Release Third-Quarter 2026 Results on October 28 The Young Dentist © theyoungdentist.com
Align Technology to Release Third-Quarter 2026 Results on October 28 © theyoungdentist.com
Align Technology will publish its third-quarter 2026 financial results on October 28 after market close. A conference call for investors and analysts will start 30 minutes later.

At 4:00 p.m. ET, or 1:00 p.m. PT, Align Technology will post its third-quarter 2026 figures in the Investor Relations section of its website.

The conference call will start at 4:30 p.m. ET, or 1:30 p.m. PT. Align said the call will cover the company's performance.

Market observers expect Align's third-quarter 2026 revenue to be approximately $1.01 billion, while the company's quarterly outlook has been cited at $1.00 billion to $1.02 billion.

MarketBeat and Zacks
 

That date is set.

The figures will offer the next formal look at a business focused on digital orthodontics and restorative dentistry. Align designs and manufactures the Invisalign® System of clear aligners, iTero™ intraoral scanners and exocad™ CAD/CAM software.

What the October release will include

Align will discuss the results during a webcasted call. Participants can pre-register through the company's call registration service. A live audio webcast will also be available through the Investor Relations section at http://investor.aligntech.com.

An archived audio webcast will be posted two hours after the call ends. It will remain available for approximately one month.

For 2026, management's outlook cited by market coverage calls for revenue growth of 3% to 4% and clear-aligner volume growth of approximately 6%, with average prices expected to be slightly lower or stable.

Zacks
 

Align says its technology supports more than 302.0 thousand doctor customers. The company also points to a worldwide consumer market opportunity of 600 million people.

The scale matters.

A digital dentistry business under review

Doctors have used the Invisalign System to treat approximately 23.5 million patients over the past 29 years, according to Align. Its portfolio brings together clear aligners, scanning and CAD/CAM software. The company does not present orthodontic treatment as a standalone product category.

That model also appeared in an earlier report on Align's SHIFT Happens campaign. The campaign addressed adult tooth movement and connected consumers with Invisalign-trained doctors in the United States. The September campaign shows the company's focus on expanding the adult patient segment.

Market expectations will offer another benchmark when the figures arrive. An earnings preview puts the consensus revenue estimate near $1.01 billion for the quarter. That figure is a market expectation, not a reported Align result.

Align describes the Align™ Digital Platform as an integrated suite of proprietary technologies and services. It serves patients and consumers, orthodontists and general dentists, laboratories and other partners. Invisalign®, iTero™, exocad™, Align™ Digital Platform and iTero Lumina are trademarks of Align Technology Inc.

Market coverage has also treated the upcoming release as another test after the previous report drew a weak reaction. The coverage cited North American retail weakness and a VAT liability in the United Kingdom as pressures on the shares.

The announcement is more than a calendar item for the dental technology supplier. It will give investors the clearest near-term look at how Align's aligner, scanner and software businesses are performing together.

No third-quarter financial outcome has been reported yet. Until the October release and call, October 28 is the evidence point for readers tracking digital dentistry. The announcement itself does not show how the quarter performed.

Topics: Dental Technology Companies Dental News & Updates Market Updates #Align Technology #Invisalign #exocad #iTero
Mara Ellison Clinical oral health editor The Young Dentist
Author

Mara Ellison

Mara Ellison is Clinical Oral Health Editor at The Young Dentist, covering restorative dentistry, endodontics, periodontal and peri-implant disease, oral diagnosis, dental imaging and treatment planning. Her editorial work focuses on what clinical evidence means in everyday practice, particularly where treatment benefits, limitations, complications and commercial claims need to be separated clearly.